SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-138296
Filing Date
2016-08-23
Accepted
2016-08-23 16:06:12
Documents
1
Period of Report
2016-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4135
  Complete submission text file 0001209191-16-138296.txt   5535
Mailing Address C/O CERULEAN PHARMA INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
BELOFF GREGG (Reporting) CIK: 0001171002 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 161847317

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations